Pax4-induced alpha-to-beta cell conversion
Pax4-induced alpha-to-beta cell conversion
批准号:
9304205
负责人:
HONGJU WU
金额:
$33.86万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2019-06-30
关键词:
AdoptedAlpha CellBeta CellBiologicalCell LineCell LineageCell SurvivalCell TherapyCell physiologyCellsClinicClinical TrialsCollaborationsDataDevelopmentDiabetes MellitusFailureFluorescenceFutureGene TransferGeneticGlucagonGraft SurvivalHormonesHumanHypertrophyInsulinInsulin ResistanceInsulin-Dependent Diabetes MellitusInvestigationIslets of LangerhansIslets of Langerhans TransplantationKnock-inLabelLettersMedicalNatural regenerationNon-Insulin-Dependent Diabetes MellitusOperative Surgical ProceduresPancreatectomyPatientsPhenotypeProteinsPublic HealthReplacement TherapyReporterSouth CarolinaTechnologyTherapeuticTransgenic MiceTreatment EfficacyUniversitiesadenoviral-mediatedbasebeta cell replacementblood glucose regulationcell typechronic pancreatitisdesignexperimental studygene therapyimprovedin vivoinnovationisletnew therapeutic targetnovelpancreas developmentpreventresearch and developmentsuccesstherapeutic developmenttherapeutic targettranscription factor
中文摘要
摘要
细胞治疗是治疗胰岛素缺乏性糖尿病的一种很有前途的策略。其中之一
在过去的十年里,这种胰岛移植策略取得了显著的成功,
但由于胰岛供应和移植物存活,其使用受到限制。另一种基于细胞的策略是
从其他类型的细胞再生产生胰岛素的β细胞。在初步研究中,我们
探索了一种从邻近的产生胰升糖素的β细胞再生α细胞的策略
胰岛。具体地说,我们研究了Pax4,一种关键的转录因子
为此目的,在发育过程中确定α-VSβ-细胞谱系。我们的数据显示
将Pax4基因转入α克隆细胞系α-TC1.9细胞,诱导其采用β-细胞
表型。我们还发现,将Pax4基因转移到原代人胰岛中显著改善了
β-细胞功能,并有间接证据表明,Pax4不仅促进β-细胞
存活,还能诱导α细胞向β细胞转化。尽管进行了广泛的初步研究,
需要更多的研究才能充分发挥Pax4和Pax4的治疗潜力
彻底了解它的行为。因此,我们在这个项目中提出了两个具体目标:1)
研究Pax4基因转移到供体人胰岛是否提高了治疗效果
胰岛移植的疗效;2)研究Pax4是否诱导α-to-β细胞
使用谱系追踪技术在原发胰岛和体内进行转化。显然,这个项目
将提供有关Pax4的治疗作用和潜力的重要信息
糖尿病治疗。
英文摘要
SUMMARY
Cell-based therapy is promising strategy for the cure of insulin deficient diabetes. One of
such strategies, islet transplantation, has achieved remarkable success over the past decade,
but its use is limited due to islet supply and graft survival. Another cell-based strategy is to
regenerate the insulin-producing β-cells from other cell types. In the preliminary studies, we
explored a strategy to regenerate β-cells from the neighboring glucagon-producing α-cells in
pancreatic islets. Specifically, we explored Pax4, a transcription factor critical for the
determination of α- vs β-cell lineage during development, for this purpose. Our data showed
Pax4 gene transfer into αTC1.9 cells, a clonal α-cell line, induced them to adopt β-cell
phenotype. We also found Pax4 gene transfer into primary human islets significantly improved
β-cell function, and had circumstantial evidence indicating Pax4 not only promoted β-cell
survival, but also induced α-to-β cell conversion. Despite the extensive preliminary studies,
more investigations are required in order to fully realize the therapeutic potential of Pax4 and
to thoroughly understand its actions. We thus propose two specific aims in this project: 1) To
investigate whether Pax4 gene transfer into donor human islets improves the therapeutic
efficacy of islet transplantation; and 2) To investigate whether Pax4 induces α-to-β cell
conversion in primary islets and in vivo using lineage-tracing technology. Clearly, the project
will provide important information regarding the therapeutic actions and potential of Pax4 for
diabetes treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pax4-induced alpha-to-beta cell conversion
-
批准号:9173658
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2016
-
负责人:HONGJU WU
-
依托单位:
Improving Islet Transplantation Outcome With Akt1
-
批准号:8545473
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2012
-
负责人:HONGJU WU
-
依托单位:
Improving Islet Transplantation Outcome With Akt1
-
批准号:8245116
-
项目类别:
-
资助金额:$32.08万
-
财政年份:2009
-
负责人:HONGJU WU
-
依托单位:
Improving Islet Transplantation Outcome With Akt1
-
批准号:8049189
-
项目类别:
-
资助金额:$31.23万
-
财政年份:2009
-
负责人:HONGJU WU
-
依托单位:
Improving islet transplantation outcome with Akt1
-
批准号:7797377
-
项目类别:
-
资助金额:$34.81万
-
财政年份:2009
-
负责人:HONGJU WU
-
依托单位:
Improving Islet Transplantation Outcome With Akt1
-
批准号:8446504
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2009
-
负责人:HONGJU WU
-
依托单位:
Improving islet transplantation outcome with Akt1
-
批准号:7661419
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2009
-
负责人:HONGJU WU
-
依托单位:
海外基金